Fortis Malar Hospitals Ltd
Fortis Malar Hospitals Ltd (FORTISMLR) last traded at ₹47.7, a market capitalisation of ₹89.5 crore, on a P/E of 688. Over the past 52 weeks the stock has ranged between ₹40.8 and ₹76. Fortis Malar Hospitals Ltd last reported results for the quarter ended Jun 2026, with sales of ₹-0 crore and net profit of ₹0.15 crore. Figures are as of 25 Aug 2026 and are not real time.
Fortis Malar Hospitals Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Fortis Malar Hospitals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹-0 cr, down 100.0% from ₹0.02 cr a year earlier. Net profit was ₹0.15 cr, down 96.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | -0 | -0 | -0 | 0.02 | 0.03 | -0 | -0 | -0 |
| Expenses | 0.47 | 0.41 | 0.37 | 0.35 | 0.41 | 0.33 | 0.55 | 0.33 |
| Operating profit | -0.47 | -0.41 | -0.37 | -0.33 | -0.38 | -0.33 | -0.55 | -0.33 |
| OPM % | — | — | — | -1,650.00% | -1,266.67% | — | — | — |
| Other income | 0.56 | 0.56 | 0.77 | 4.61 | 0.52 | 0.52 | 0.66 | 0.53 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Depreciation | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit before tax | 0.09 | 0.15 | 0.4 | 4.28 | 0.14 | 0.19 | 0.11 | 0.2 |
| Tax % | -0.00% | 93.33% | 10.00% | 3.04% | 92.86% | 89.47% | 136.36% | 25.00% |
| Net profit | 0.09 | 0.01 | 0.36 | 4.15 | 0.01 | 0.02 | -0.05 | 0.15 |
| EPS (₹) | 0.05 | 0.01 | 0.19 | 2.21 | 0.01 | 0.01 | -0.03 | 0.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fortis Malar Hospitals Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 69.24 | 86.18 | 85.95 | 59.01 | -0 | -0 | 0.03 |
| Operating profit | -6.34 | 3.44 | 4.57 | -1.21 | -2.14 | -1.62 | -1.59 |
| OPM % | -9.16% | 3.99% | 5.32% | -2.05% | — | -3,140.00% | -5,300.00% |
| Net profit | -7.87 | -8.27 | -15.48 | 45.32 | 0.39 | 4.14 | 0.13 |
| EPS (₹) | -4.20 | -4.41 | -8.26 | 24.18 | 0.21 | 2.21 | 0.07 |
TTM is the trailing twelve months to the most recent quarter.
Fortis Malar Hospitals Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 50%
- 10 Years
- -5%
- 5 Years
- 18%
- 3 Years
- 31%
- TTM
- -97%
- 10 Years
- -5%
- 5 Years
- -7%
- 3 Years
- -6%
- 1 Year
- -30%
- 10 Years
- -5%
- 5 Years
- -8%
- 3 Years
- -2%
- Last Year
- 13%
Fortis Malar Hospitals Ltd shareholding pattern
Promoters held 62.71% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.07%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% | 62.71% |
| DIIs | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Public | 37.22% | 37.22% | 37.23% | 37.24% | 37.21% | 37.21% | 37.22% | 37.22% |
| No. of shareholders | 18,860 | 21,547 | 26,918 | 27,832 | 27,644 | 27,022 | 26,259 | 25,734 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Fortis Malar Hospitals Ltd corporate filings
- Relevant Disclosure is attachedCompany Updatelow impact
Cruxal's analysis: Fortis Malar Hospitals Ltd has published a statutory notice in newspapers regarding its…
Read the full analysis - Relevant Disclosure is attachedResulthigh impact
Cruxal's analysis: Fortis Malar Hospitals Limited has reported a standalone Profit After Tax (PAT) of INR…
Read the full analysis - Approval of Financial Results for the quarter ended June 30, 2026Board Meetingmedium impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Fortis Malar Hospitals Ltd
Cruxal reads every Fortis Malar Hospitals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.